Drug ID: | NPD4739 |
Drug Name: | |
Molecular Formula: | C21H30N2O8S |
Canonical SMILES: | CSCC[C@@H](C(=NCCc1ccc(c(c1)OC(=O)OCC)OC(=O)OCC)O)N=C(O)C |
Standard InCHI: | InChI=1S/C21H30N2O8S/c1-5-28-20(26)30-17-8-7-15(13-18(17)31-21(27)29-6-2)9-11-22-19(25)16(10-12-32-4)23-14(3)24/h7-8,13,16H,5-6,9-12H2,1-4H3,(H,22,25)(H,23,24)/t16-/m0/s1 |
Standard InCHIKey: | ZLVMAMIPILWYHQ-INIZCTEOSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNAP001418 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 71137 |
ChEBI | |
CAS Number |
Molecular Weight | 470.17 |
ALogP | 1.7739 |
MLogP | 2.56 |
XLogP | 4.352 |
HDA | 8 |
HBD | 2 |
Rotatable Bonds | 22 |
TPSA | 161.54 |
RO5 Violation | 1 |